SCHEMBL38650658

SCHEMBL38650658

C#CCNC(=O)CC=CC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.39
MAOA P21397 1/20 0.36
RAB9A P51151 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
MAOB P27338 1/20 0.36
GABRR1 P24046 2/20 0.35
GABRR2 P28476 2/20 0.35
BLM P54132 2/20 0.35
GABRR3 A8MPY1 1/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
APEX1 P27695 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
KDM1A O60341 1/20 0.34
CNR2 P34972 1/20 0.34
CAPN1 P07384 1/20 0.31
MTNR1A P48039 1/20 0.31
MTNR1B P49286 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27999002 0.74 ALDH1A1 (0.41) GABRR1GABRR2BLMGABRR3LMNA
SCHEMBL1755617 0.74 L3MBTL1 (0.55) L3MBTL1MAOARAB9ASMN1; SMN2NPC1
SCHEMBL15048668 0.74 L3MBTL1 (0.55) L3MBTL1MAOARAB9ASMN1; SMN2NPC1
SCHEMBL15048669 0.74 L3MBTL1 (0.55) L3MBTL1MAOARAB9ASMN1; SMN2NPC1
SCHEMBL2365907 0.73 TSHR (0.42) L3MBTL1GABRR1GABRR2BLMGABRR3
SCHEMBL14916620 0.72 L3MBTL1 (0.41) L3MBTL1MAOARAB9ASMN1; SMN2NPC1
SCHEMBL14916621 0.72 L3MBTL1 (0.41) L3MBTL1MAOARAB9ASMN1; SMN2NPC1
SCHEMBL29957485 0.70 KDM1A (0.39) RAB9ASMN1; SMN2NPC1MAOBKDM1A
SCHEMBL256677 0.68
SCHEMBL13844956 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122005525-A Use of glutaconic acid to enhance T cell antitumor effect by metabolic reprogramming 浙江大学 2026-05-12 CN disclosed